We recently looked at the top pharmaceutical companies across developed markets to assess how successful they’ve been in reducing their natural capital impacts.
Our analysis found that only 3 of the largest companies (by revenue) in developed markets outperformed the sector average in terms of reducing their overall natural capital impacts (measured by impact intensities as seen in the graph below). AstraZeneca performed the best in reducing their overall natural capital impacts, reducing it by 19%, with Amgen and Zoetis also reducing their impacts by 14% and 12% respectively.
Zooming in to just GHG emissions, the picture looks better: the top 10 companies in developed markets performed well in reducing their GHG emissions compared to the industry average ($570 per million USD revenue). Vertex Pharmaceuticals and AstraZeneca led the way with 28% and 20% impact reduction rates respectively, outpacing the average GHG impact reduction rate of 12%.
Finally we noticed how Zoetis and AstraZeneca stood out in reducing their waste impact intensity compared to the sector average, reducing their waste intensity by 20% and 19% respectively. Meanwhile, some of their peers, like AbbVie saw a concerning 64% increase in waste impact intensity over the same period.
If you’re interested in evaluating your company’s environmental impact across its operations and comparing it with industry peers, get in touch with GIST Impact. Our platform can assist you in measuring and benchmarking your environmental performance within the sector, giving you location-specific, cross-comparable insights so you can fully understand what’s most material to your business.
Learn more about our solution on Environmental Benchmarking or reach out to us at info@gistimpact.com.
Dive into the cutting-edge conversations shaping the energy sector in Gigawaters: Season 3, the Energy Voice podcast in collaboration with Ørsted. Hosted by renewables reporter Michael Behr, this season unpacks…
Biodiversity loss is an increasing risk for the planet, with wide-ranging threats that include economic decline and accelerated climate change. Alongside custodians, lenders and investors, financial institutions are at the…
London, Wednesday 27th – TTB Sport and GIST Impact have announced a landmark partnership aimed at accelerating the sports industry’s adoption of social value as a key decision making tool….
𝗖𝗢𝗣𝟮𝟵 𝗶𝘀 𝗵𝗲𝗿𝗲, 𝗮𝗻𝗱 𝘁𝗵𝗲 𝘄𝗼𝗿𝗹𝗱’𝘀 𝗳𝗼𝗰𝘂𝘀 𝗶𝘀 𝗼𝗻𝗰𝗲 𝗮𝗴𝗮𝗶𝗻 𝗼𝗻 𝗼𝘂𝗿 𝗰𝗼𝗹𝗹𝗲𝗰𝘁𝗶𝘃𝗲 𝗿𝗲𝘀𝗽𝗼𝗻𝘀𝗲 𝘁𝗼 𝗰𝗹𝗶𝗺𝗮𝘁𝗲 𝗰𝗵𝗮𝗻𝗴𝗲. As delegates gather in Baku, Azerbaijan, from 11 – 22 November, there’s a…
In today’s world, businesses are increasingly expected to demonstrate their contribution to society. One of the most effective ways to do this is by measuring their social impact. Social impact…
Did you know we’ve been working with Microsoft to measure the social impact of some of their key programmes? Since 2022, Microsoft and GIST Impact partnered to track and measure…